Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-035106)

Filing Details

Accession Number:: 0001181431-13-035106
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-14 21:30:58
Reporting Period:: 2013-06-12

Filing Date:: 2013-06-14
Accepted Time:: 2013-06-14 21:30:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411879	Innovus Pharmaceuticals Inc.	INNV	Blank Checks (6770)	870324697

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1478733	Bassam Damaj	4275 Executive Square, Suite 200 La Jolla CA 92037	President & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-12	287,448	$0.32	5,051,270	No	4	P	Direct
Common Stock	Acquisiton	2013-06-12	129,393	$0.32	129,393	No	4	P	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By Spouse

Footnotes

Consists of (a) 250,406 held in the reporting person's name, (b) 4,507,308 shares held together with the reporting person's spouse and (c) 293,556 shares held in the reporting person's IRAs.